Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  UnitedHealth Group    UNH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Analysis summary4-Traders Strategies

Anaïs Lozach

 
 
share with twitter share with LinkedIn share with facebook
share via e-mail

In an accumulation phase

Strategy published on 05/18/2017 | 14:16
long trade on a pullback
Conditional Order Terminated
Entry price : 163.4$ | Target : 176$ | Stop-loss : 161.9$ | Cancellation Level : 171.8$ | Potential : 7.71%
UnitedHealth Group Inc shares are locked into a trading range. This phase will eventually have to end with a return of a clear trend.
Investors should buy the stock at current prices near $ 163.4 in order to target the $ 176.
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Historically, the company has been releasing figures that are above expectations.
  • As regards fundamentals, the enterprise value to sales ratio is at 0.89 for the current period. Therefore, the company is undervalued.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 152.86 USD

Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2017 200 B
EBIT 2017 15 354 M
Net income 2017 9 244 M
Debt 2017 15 366 M
Yield 2017 1,19%
P/E ratio 2017 22,02
P/E ratio 2018 20,21
EV / Sales 2017 1,08x
EV / Sales 2018 0,96x
Capitalization 201 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart UNITEDHEALTH GROUP
Duration : Period : Day
UnitedHealth Group Technical Analysis Chart | UNH | US91324P1021 | 4-Traders
Duration : Period : Week
UnitedHealth Group Technical Analysis Chart | UNH | US91324P1021 | 4-Traders